~~<i id='6916CA022F'><strike id='6916CA022F'><tt id='6916CA022F'><pre id='6916CA022F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

focus

author：knowledge 2025-09-28 00:25:45 - browse：147

Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： FDA approves Sage Therapeutics’ rapid

hotspot

focus

hotspot

focus

entertainment

MollyFerguson/STATAnavexLifeSciencesisinatoughspot.Theserialdissemblerofclinicaltrialresultsmightbef

WSS

Naloxone nonprofit donates 200,000 doses after FDA approval

Methadone doses haven’t kept up in the age of fentanyl

Wegovy trial has doctors encouraged over new possibilities

Alnylam reports growth in sales of rare disease treatments

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

American woman, child freed after being kidnapped in Haiti last month

knowledge

focus

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alnylam reports growth in sales of rare disease treatments

ChatGPT in medicine: STAT answers readers' burning questions

Physicians aren't 'burning out.' They're suffering from moral injury

Malaria cases in Florida and Texas: Here’s what you need to know

2 officers injured in shooting in Orlando, police say

New air purifier tech could be key to improving indoor air quality

The a glaring gap in research on serious mental illness and primary care

Jerome Adams on the need for new antivirals for Covid

South Korea throws huge K

focus

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

The best solution to the drug shortages problem

NIH trials fail to test meaningful long Covid therapies, experts say

FDA scientists endorse Pfizer/BioNTech Covid

Naloxone nonprofit donates 200,000 doses after FDA approval

hotspot

focus

entertainment

entertainment